- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Triple Layer sign on OCT useful diagnostic tool for diagnosing non-exudative macular neovascularization: Study
A recent study found that the triple-layer sign (TLS) obtained on optical coherence tomography has high sensitivity and specificity in identifying treatment-naïve non-exudative type-1 macular neovascularization (NE-MNV) in age-related macular degeneration (AMD), as per results published in the journal Graefe's Archive for Clinical and Experimental Ophthalmology.
treatment-naïve non-exudative type-1 macular neovascularization (NE-MNV) in age-related macular degeneration (AMD) can be quite challenging to diagnose. Optical coherence tomography is done to detect three layers, such as the retinal pigment epithelium, neovascular tissue, and Bruch's membrane, to identify neovascularization. This is called the triple-layer sign. Researchers from the Department of Ophthalmology in France and Italy conducted a study to assess the sensitivity and specificity of the “triple layer sign” that can be used to diagnose treatment-naïve non-exudative type-1 macular neovascularization (NE-MNV) in age-related macular degeneration (AMD).
Two masked retinal experts conducted a cross-sectional study to evaluate the presence of TLS in eyes with NE-MNV. Individuals with a retinal pigment elevation without exudation due to other causes than NE-MNV in AMD, such as medium-large drusen, cuticular drusen, and basal laminar deposits (BlamD), were used as controls.
Findings:
- About 130 eyes of 98 consecutive patients who met the inclusion criteria were involved in the study.
- A total of 40 eyes from 40 patients met the criteria for NE-MNV secondary to the AMD group.
- They included 27 females and 13 males, with a mean age of 73.8 ± 8.0 years.
- About 90 eyes of 58 patients were added to the control group.
- About 31 eyes were included in the medium-to-large drusen sub-group, 32 in the cuticular drusen sub-group, and 27 in the BlamD group.
- On structural OCT, non-exudative MNV shows TLS defined as triple hyper-reflective bands on OCT frames.
- The TLS was observed in 39/40 patients with NE-MNV and 8/90 controls.
- The first band corresponded to the retinal pigment epithelium (RPE), the second band with the neovascular tissue (flash), and a less reflective band was observed near the second band. The third hyper-reflective band represented Bruch's membrane (BM).
- The sensitivity and specificity of the TLS for diagnosing NE-MNV were 97% and 91%, respectively.
Thus, the authors concluded that the triple-layer sign representing the retinal epithelium neovascular tissue and Bruch’s membrane displayed high sensitivity and specificity. This underscores the importance of using the triple-layer sign for early detection and treatment planning, as it is a noninvasive diagnostic approach that also helps improve diagnostic accuracy.
Further reading: Capuano, V., Sacconi, R., Miere, A. et al. The “triple-layer sign”: an optical coherence tomography signature for the detection of non-exudative macular neovascularization. Graefes Arch Clin Exp Ophthalmol 262, 3847–3855 (2024). https://doi.org/10.1007/s00417-024-06585-9.
Take-home points:
- In this study, the authors investigated the utility of the "triple-layer sign" (TLS) in diagnosing non-exudative macular neovascularization (NE-MNV) in patients with age-related macular degeneration.
- Optical coherence tomography was performed to identify three layers (retinal pigment epithelium, neovascular tissue, and Bruch's membrane). Overall, 40 of 130 eyes demonstrated evidence of NE-MNV.
- The TLS was observed in 39 of 40 patients with NE-MNV, compared with 8 of 90 patients in the control group. The overall sensitivity of the TLS for diagnosing NE-MNV was 91%, with a specificity of 97%. Inter-rater agreement for the identification of the TLS was also high.
- The TLS may represent a valuable diagnostic tool for identifying NE-MNV in patients with age-related macular degeneration.
BDS, MDS
Dr.Niharika Harsha B (BDS,MDS) completed her BDS from Govt Dental College, Hyderabad and MDS from Dr.NTR University of health sciences(Now Kaloji Rao University). She has 4 years of private dental practice and worked for 2 years as Consultant Oral Radiologist at a Dental Imaging Centre in Hyderabad. She worked as Research Assistant and scientific writer in the development of Oral Anti cancer screening device with her seniors. She has a deep intriguing wish in writing highly engaging, captivating and informative medical content for a wider audience. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751